HER3 beyond the canonical paradigm: a versatile signaling hub in oncogenesis and therapeutic resistance.
Saved in:
| Title: | HER3 beyond the canonical paradigm: a versatile signaling hub in oncogenesis and therapeutic resistance. |
|---|---|
| Authors: | Li Y; Department of Radiation Oncology and Therapy, The First Hospital of Jilin University, Changchun, China., Wang Z; Department of Radiation Oncology and Therapy, The First Hospital of Jilin University, Changchun, China., Gu M; Department of Radiation Oncology and Therapy, The First Hospital of Jilin University, Changchun, China., Huang F; Department of Radiation Oncology and Therapy, The First Hospital of Jilin University, Changchun, China., Chang P; Department of Radiation Oncology and Therapy, The First Hospital of Jilin University, Changchun, China. changpengyu@jlu.edu.cn. |
| Source: | Journal of translational medicine [J Transl Med] 2026 Mar 12; Vol. 24 (1). Date of Electronic Publication: 2026 Mar 12. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876 (Electronic) Linking ISSN: 14795876 NLM ISO Abbreviation: J Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1479-5876 |
|---|---|
| DOI: | 10.1186/s12967-026-07934-4 |
